HR c.2902_2903delinsCC ;(p.K968P)

Variant ID: 8-21977347-TT-GG

NM_005144.4(HR):c.2902_2903delinsCC;(p.K968P)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.

Eclinicalmedicine
Szubert, Alex J AJ; Pollock, Katrina M KM; Cheeseman, Hannah M HM; Alagaratnam, Jasmini J; Bern, Henry H; Bird, Olivia O; Boffito, Marta M; Byrne, Ruth R; Cole, Tom T; Cosgrove, Catherine A CA; Faust, Saul N SN; Fidler, Sarah S; Galiza, Eva E; Hassanin, Hana H; Kalyan, Mohini M; Libri, Vincenzo V; McFarlane, Leon R LR; Milinkovic, Ana A; O'Hara, Jessica J; Owen, David R DR; Owens, Daniel D; Pacurar, Mihaela M; Rampling, Tommy T; Skene, Simon S; Winston, Alan A; Woolley, James J; Yim, Yee Ting N YTN; Dunn, David T DT; McCormack, Sheena S; Shattock, Robin J RJ; ,
Publication Date: 2023-02

Variant appearance in text: HR: K968P
PubMed Link: 36684396
Variant Present in the following documents:
  • mmc3.pdf
View BVdb publication page



Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.

Eclinicalmedicine
Pollock, Katrina M KM; Cheeseman, Hannah M HM; Szubert, Alexander J AJ; Libri, Vincenzo V; Boffito, Marta M; Owen, David D; Bern, Henry H; O'Hara, Jessica J; McFarlane, Leon R LR; Lemm, Nana-Marie NM; McKay, Paul F PF; Rampling, Tommy T; Yim, Yee Ting N YTN; Milinkovic, Ana A; Kingsley, Cherry C; Cole, Tom T; Fagerbrink, Susanne S; Aban, Marites M; Tanaka, Maniola M; Mehdipour, Savviz S; Robbins, Alexander A; Budd, William W; Faust, Saul N SN; Hassanin, Hana H; Cosgrove, Catherine A CA; Winston, Alan A; Fidler, Sarah S; Dunn, David T DT; McCormack, Sheena S; Shattock, Robin J RJ; ,
Publication Date: 2022-02

Variant appearance in text: HR: K968P
PubMed Link: 35043093
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates.

Science Advances
He, Linling L; Lin, Xiaohe X; Wang, Ying Y; Abraham, Ciril C; Sou, Cindy C; Ngo, Timothy T; Zhang, Yi Y; Wilson, Ian A IA; Zhu, Jiang J
Publication Date: 2021-03

Variant appearance in text: HR: K968P
PubMed Link: 33741598
Variant Present in the following documents:
  • abf1591.pdf
View BVdb publication page



Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment.

The Journal Of Biological Chemistry
Malladi, Sameer Kumar SK; Singh, Randhir R; Pandey, Suman S; Gayathri, Savitha S; Kanjo, Kawkab K; Ahmed, Shahbaz S; Khan, Mohammad Suhail MS; Kalita, Parismita P; Girish, Nidhi N; Upadhyaya, Aditya A; Reddy, Poorvi P; Pramanick, Ishika I; Bhasin, Munmun M; Mani, Shailendra S; Bhattacharyya, Sankar S; Joseph, Jeswin J; Thankamani, Karthika K; Raj, V Stalin VS; Dutta, Somnath S; Singh, Ramandeep R; Nadig, Gautham G; Varadarajan, Raghavan R
Publication Date: 2021

Variant appearance in text: HR: K968P
PubMed Link: 33154165
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates.

Biorxiv : The Preprint Server For Biology
He, Linling L; Lin, Xiaohe X; Wang, Ying Y; Abraham, Ciril C; Sou, Cindy C; Ngo, Timothy T; Zhang, Yi Y; Wilson, Ian A IA; Zhu, Jiang J
Publication Date: 2021-04-05

Variant appearance in text: HR: K968P
PubMed Link: 32995773
Variant Present in the following documents:
  • nihpp-2020.09.14.296715.pdf
View BVdb publication page